Loring Wolcott & Coolidge Fiduciary Advisors LLP MA Has $6.48 Million Position in Colgate-Palmolive Company $CL

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA increased its position in Colgate-Palmolive Company (NYSE:CL) by 26.8% during the third quarter, Holdings Channel reports. The firm owned 82,611 shares of the company’s stock after buying an additional 17,485 shares during the quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s holdings in Colgate-Palmolive were worth $6,480,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Towercrest Capital Management raised its stake in Colgate-Palmolive by 1,243.6% in the third quarter. Towercrest Capital Management now owns 64,117 shares of the company’s stock valued at $5,125,000 after buying an additional 59,345 shares during the period. Associated Banc Corp raised its position in shares of Colgate-Palmolive by 4.7% in the third quarter. Associated Banc Corp now owns 72,768 shares of the company’s stock valued at $5,817,000 after purchasing an additional 3,269 shares during the period. Forum Financial Management LP lifted its stake in shares of Colgate-Palmolive by 4.7% during the 3rd quarter. Forum Financial Management LP now owns 5,293 shares of the company’s stock worth $423,000 after buying an additional 238 shares during the last quarter. Legacy Trust boosted its holdings in shares of Colgate-Palmolive by 7.2% during the 3rd quarter. Legacy Trust now owns 7,413 shares of the company’s stock worth $593,000 after buying an additional 500 shares during the period. Finally, MASTERINVEST Kapitalanlage GmbH grew its stake in Colgate-Palmolive by 6.5% in the 3rd quarter. MASTERINVEST Kapitalanlage GmbH now owns 29,882 shares of the company’s stock valued at $2,389,000 after buying an additional 1,812 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 0.7%

CL opened at $81.44 on Monday. The company has a 50-day simple moving average of $78.71 and a 200 day simple moving average of $81.91. The stock has a market capitalization of $65.64 billion, a price-to-earnings ratio of 22.81, a P/E/G ratio of 5.52 and a beta of 0.30. The company has a quick ratio of 0.60, a current ratio of 0.93 and a debt-to-equity ratio of 5.90. Colgate-Palmolive Company has a twelve month low of $74.54 and a twelve month high of $100.18.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.02. Colgate-Palmolive had a net margin of 14.47% and a return on equity of 333.39%. The business had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.17 billion. During the same quarter last year, the business posted $0.91 EPS. The firm’s revenue for the quarter was up 1.9% on a year-over-year basis. Analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be paid a $0.52 dividend. The ex-dividend date of this dividend is Wednesday, January 21st. This represents a $2.08 annualized dividend and a yield of 2.6%. Colgate-Palmolive’s dividend payout ratio (DPR) is 58.26%.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. Royal Bank Of Canada raised Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 target price on the stock in a research report on Tuesday, December 9th. Jefferies Financial Group set a $85.00 price objective on Colgate-Palmolive in a report on Tuesday, December 16th. Weiss Ratings reissued a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, October 8th. JPMorgan Chase & Co. upped their price target on shares of Colgate-Palmolive from $87.00 to $88.00 and gave the company an “overweight” rating in a research note on Thursday, December 18th. Finally, Citigroup dropped their price objective on shares of Colgate-Palmolive from $105.00 to $95.00 and set a “buy” rating for the company in a research note on Monday, November 3rd. Eleven equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Colgate-Palmolive currently has a consensus rating of “Moderate Buy” and an average target price of $88.19.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.